A Study to Assess Bioavailability & Food Effect of Different Liquid and Capsule Formulations of TMC435.
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the relative bioavailability and the short-term
safety and tolerability of TMC435 following administration of 3 single oral doses of 150 mg,
given as different formulations in healthy adult participants. In addition, this study is to
assess for the acceptability of the taste of both liquid formulations.